Bing Xing
-
- Pituitary Gland Disorders and Treatments 119
- Growth Hormone and Insulin-like Growth Factors 52
- Adrenal Hormones and Disorders 8
- Genetics top 2%
- Glioma Diagnosis and Treatment 36
- Cancer Research top 5%
- Surgery top 5%
- Adrenal and Paraganglionic Tumors 36
- Head and Neck Surgical Oncology 8
- Epidemiology top 10%
- Meningioma and schwannoma management 17
-
- TGF-β signaling in diseases 10
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Bing Xing
168 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 147
- Endocrinology, Diabetes and Metabolism 1.1k
- Genetics 456
- Cancer Research 315
- Surgery 584
- Epidemiology 433
Countries citing papers authored by Bing Xing
This map shows the geographic impact of Bing Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Xing more than expected).
Fields of papers citing papers by Bing Xing
This network shows the impact of papers produced by Bing Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Xing. The network helps show where Bing Xing may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bing Xing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 40 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 5 | |
| 10 | 2020 | 2 | |
| 11 | 2019 | 4 | |
| 12 | 2019 | 17 | |
| 13 | 2018 | 14 | |
| 14 | 2017 | 20 | |
| 15 | 2017 | 20 | |
| 16 | 2017 | 8 | |
| 17 | 2016 | 1 | |
| 18 | 2016 | 29 | |
| 19 | [Causes and treatment of acute visual dysfunction after transsphenoidal surgery of pituitary adenoma]. | 2015 | 1 |
| 20 | 2014 | 2 |
About Bing Xing
Bing Xing is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Cancer Research, Surgery and Neurology, having authored 177 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (119 papers), Growth Hormone and Insulin-like Growth Factors (52 papers), Glioma Diagnosis and Treatment (36 papers), Adrenal and Paraganglionic Tumors (36 papers), Meningioma and schwannoma management (17 papers), TGF-β signaling in diseases (10 papers), Head and Neck Surgical Oncology (8 papers) and Adrenal Hormones and Disorders (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.1k citations), Genetics (456 citations), Cancer Research (315 citations), Surgery (584 citations) and Epidemiology (433 citations). Bing Xing has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiaopeng Guo, Renzhi Wang, Lu Gao, Wei Lian, Yong Yao, Kan Deng, Ming Feng, Zihao Wang, Xinjie Bao and Wenbin Ma. Their work appears in journals such as Medicine, World Neurosurgery, Frontiers in Endocrinology, Pituitary and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.